Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity

Lu,Sumei; Ma,Yongmei; Sun,Tao; Ren,Rui; Zhang,Xiaoning; Ma,Wanshan

doi:10.3892/or.2016.4678

Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity

Authors:
- Sumei Lu
- Yongmei Ma
- Tao Sun
- Rui Ren
- Xiaoning Zhang
- Wanshan Ma
View Affiliations

Affiliations: Department of Laboratory Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China
Published online on: March 16, 2016 https://doi.org/10.3892/or.2016.4678
Pages: 2984-2990

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

α-fetoprotein (AFP) is a valuable tumor marker for many types of cancers, including primary gastric cancer (GC). However, the effects of AFP expression on the metastasis and anoikis sensitivity of GC remain unclear. The present study aimed to explore the role and possible mechanism of AFP in the invasion and metastasis of GC AGS cells, particularly in the anoikis sensitivity of AGS cells. In the present study, the expression of AFP in cultured AGS cells was assayed firstly by RT-PCR, western blotting and sequencing. Then, a specific AFP siRNA was applied to interfere with AFP expression and poly(2-hydroxyethyl methacrylate) (poly-HEMA) was used to block cell anchorage. The invasion and metastatic ability, and anoikis sensitivity detections were conducted based on Transwell chamber assay, anoikis assay kit and western blotting. Our results confirmed the expression of AFP in AGS cells. Then, we found that interference of AFP with siRNA attenuated the invasion and metastasis of AGS cells and induced a significant upregulation of E-cadherin and downregulation of N-cadherin expression (P<0.05). Cell apoptosis and anoikis were induced when cell anchorage was blocked by poly-HEMA treatment, which was exacerbated significantly when cells were exposed to AFP siRNA. Moreover, interference of AFP when cell anchorage was blocked enhanced the expression of the pro-apoptotic proteins Bax, caspase-3 and -9, and decreased the expression of the anti-apoptotic protein B-cell lymphoma-2 (Bcl-2). In conclusion, the present study demonstrated that interference of AFP reduced AGS cell invasion and metastasis by enhancing anoikis sensitivity. The present study provides new insight for the treatment of GC and suggests AFP as a potential therapeutic target by regulating anoikis sensitivity.

View Figures

View References

1	Woo HD, Lee J, Choi IJ, Kim CG, Lee JY, Kwon O and Kim J: Dietary flavonoids and gastric cancer risk in a Korean population. Nutrients. 6:4961–4973. 2014. View Article : Google Scholar : PubMed/NCBI
2	Yan S, Li B, Bai ZZ, Wu JQ, Xie DW, Ma YC, Ma XX, Zhao JH and Guo XJ: Clinical epidemiology of gastric cancer in Hehuang valley of China: A 10-year epidemiological study of gastric cancer. World J Gastroenterol. 20:10486–10494. 2014. View Article : Google Scholar : PubMed/NCBI
3	Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of gastric cancer in Asia: Resource-stratified guidelines. Lancet Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
4	Murray MJ and Nicholson JC: α-Fetoprotein. Arch Dis Child Educ Pract Ed. 96:141–147. 2011. View Article : Google Scholar : PubMed/NCBI
5	Osada M, Aishima S, Hirahashi M, Takizawa N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R and Oda Y: Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum Pathol. 45:1243–1250. 2014. View Article : Google Scholar : PubMed/NCBI
6	Shimada H, Noie T, Ohashi M, Oba K and Takahashi Y: Clinical significance of serum tumor markers for gastric cancer: A systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 17:26–33. 2014. View Article : Google Scholar
7	Yao DF, Dong ZZ and Yao M: Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 6:241–247. 2007.PubMed/NCBI
8	Hirajima S, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H and Otsuji E: Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J Gastroenterol. 19:6055–6061. 2013. View Article : Google Scholar : PubMed/NCBI
9	Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
10	Lu S, Yu L, Mu Y, Ma J, Tian J, Xu W and Wang H: Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells. Mol Med Rep. 10:53–60. 2014.PubMed/NCBI
11	Yu L, Lu S, Tian J, Ma J, Li J, Wang H and Xu W: TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis. Oncol Rep. 27:416–422. 2012.
12	Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Nakashima S, Hokita S and Aikou T: Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology. 53:338–341. 2006.PubMed/NCBI
13	Barranco SC, Townsend CM Jr, Casartelli C, Macik BG, Burger NL, Boerwinkle WR and Gourley WK: Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 43:1703–1709. 1983.PubMed/NCBI
14	Rac J, Haas F, Schumacher A, Middeldorp JM, Delecluse HJ, Speck RF, Bernasconi M and Nadal D: Telomerase activity impacts on Epstein-Barr virus infection of AGS cells. PLoS One. 10:e01236452015. View Article : Google Scholar : PubMed/NCBI
15	Shen XJ, Zhang H, Tang GS, Wang XD, Zheng R, Wang Y, Zhu Y, Xue XC and Bi JW: Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Int J Biol Sci. 11:370–379. 2015. View Article : Google Scholar : PubMed/NCBI
16	Yuan TM, Liang RY, Chueh PJ and Chuang SM: Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines. Oncol Lett. 9:1861–1868. 2015.PubMed/NCBI
17	Chen J, Röcken C, Treiber G, Jentsch-Ulrich K, Malfertheiner P and Ebert MP: Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma. Dig Dis. 21:357–362. 2003. View Article : Google Scholar
18	Yu W, Qiao Y, Tang X, Ma L, Wang Y, Zhang X, Weng W, Pan Q, Yu Y, Sun F, et al: Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal. 26:2961–2968. 2014. View Article : Google Scholar : PubMed/NCBI
19	Derouet MF, Liu G and Darling GE: MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. PLoS One. 9:e1155892014. View Article : Google Scholar
20	Pajak B, Gajkowska B and Orzechowski A: Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol. 46:129–135. 2008. View Article : Google Scholar : PubMed/NCBI
21	Debierre-Grockiego F: Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies. Apoptosis. 9:717–728. 2004. View Article : Google Scholar : PubMed/NCBI
22	Hardwick JM and Soane L: Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol. 5:a0087222013. View Article : Google Scholar : PubMed/NCBI
23	Qin S, Yang C, Wang X, Xu C, Li S, Zhang B and Ren H: Overexpression of Smac promotes cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells. Cancer Biother Radiopharm. 28:177–182. 2013. View Article : Google Scholar